Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. 2009

Gro Vatne Røsland, and Agnete Svendsen, and Anja Torsvik, and Ewa Sobala, and Emmet McCormack, and Heike Immervoll, and Josef Mysliwietz, and Joerg-Christian Tonn, and Roland Goldbrunner, and Per Eystein Lønning, and Rolf Bjerkvig, and Christian Schichor
Department of Biomedicine, University of Bergen, Bergen N-5009, Norway.

Human mesenchymal stem cells (hMSC) aid in tissue maintenance and repair by differentiating into specialized cell types. Due to this ability, hMSC are currently being evaluated for cell-based therapies of tissue injury and degenerative diseases. However, extensive expansion ex vivo is a prerequisite to obtain the cell numbers required for human cell-based therapy protocols. Recent studies indicate that hMSC may contribute to cancer development and progression either by acting as cancer-initiating cells or through interactions with stromal elements. If spontaneous transformation ex vivo occurs, this may jeopardize the use of hMSC as therapeutic tools. Whereas murine MSC readily undergo spontaneous transformation, there are conflicting reports about spontaneous transformation of hMSC. We have addressed this controversy in a two-center study by growing bone marrow-derived hMSC in long-term cultures (5-106 weeks). We report for the first time spontaneous malignant transformation to occur in 45.8% (11 of 24) of these cultures. In comparison with hMSC, the transformed mesenchymal cells (TMC) showed a significantly increased proliferation rate and altered morphology and phenotype. In contrast to hMSC, TMC grew well in soft agar assays and were unable to undergo complete differentiation. Importantly, TMC were highly tumorigenic, causing multiple fast-growing lung deposits when injected into immunodeficient mice. We conclude that spontaneous malignant transformation may represent a biohazard in long-term ex vivo expansion of hMSC. On the other hand, this spontaneous transformation process may represent a unique model for studying molecular pathways initiating malignant transformation of hMSC.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Gro Vatne Røsland, and Agnete Svendsen, and Anja Torsvik, and Ewa Sobala, and Emmet McCormack, and Heike Immervoll, and Josef Mysliwietz, and Joerg-Christian Tonn, and Roland Goldbrunner, and Per Eystein Lønning, and Rolf Bjerkvig, and Christian Schichor
December 2013, Cell death & disease,
Gro Vatne Røsland, and Agnete Svendsen, and Anja Torsvik, and Ewa Sobala, and Emmet McCormack, and Heike Immervoll, and Josef Mysliwietz, and Joerg-Christian Tonn, and Roland Goldbrunner, and Per Eystein Lønning, and Rolf Bjerkvig, and Christian Schichor
January 2010, Cells, tissues, organs,
Gro Vatne Røsland, and Agnete Svendsen, and Anja Torsvik, and Ewa Sobala, and Emmet McCormack, and Heike Immervoll, and Josef Mysliwietz, and Joerg-Christian Tonn, and Roland Goldbrunner, and Per Eystein Lønning, and Rolf Bjerkvig, and Christian Schichor
January 2013, Tsitologiia,
Gro Vatne Røsland, and Agnete Svendsen, and Anja Torsvik, and Ewa Sobala, and Emmet McCormack, and Heike Immervoll, and Josef Mysliwietz, and Joerg-Christian Tonn, and Roland Goldbrunner, and Per Eystein Lønning, and Rolf Bjerkvig, and Christian Schichor
January 2014, PloS one,
Gro Vatne Røsland, and Agnete Svendsen, and Anja Torsvik, and Ewa Sobala, and Emmet McCormack, and Heike Immervoll, and Josef Mysliwietz, and Joerg-Christian Tonn, and Roland Goldbrunner, and Per Eystein Lønning, and Rolf Bjerkvig, and Christian Schichor
December 2012, Cell biochemistry and function,
Gro Vatne Røsland, and Agnete Svendsen, and Anja Torsvik, and Ewa Sobala, and Emmet McCormack, and Heike Immervoll, and Josef Mysliwietz, and Joerg-Christian Tonn, and Roland Goldbrunner, and Per Eystein Lønning, and Rolf Bjerkvig, and Christian Schichor
October 2007, Cancer research,
Gro Vatne Røsland, and Agnete Svendsen, and Anja Torsvik, and Ewa Sobala, and Emmet McCormack, and Heike Immervoll, and Josef Mysliwietz, and Joerg-Christian Tonn, and Roland Goldbrunner, and Per Eystein Lønning, and Rolf Bjerkvig, and Christian Schichor
January 2011, International journal of biological sciences,
Gro Vatne Røsland, and Agnete Svendsen, and Anja Torsvik, and Ewa Sobala, and Emmet McCormack, and Heike Immervoll, and Josef Mysliwietz, and Joerg-Christian Tonn, and Roland Goldbrunner, and Per Eystein Lønning, and Rolf Bjerkvig, and Christian Schichor
December 2007, The Libyan journal of medicine,
Gro Vatne Røsland, and Agnete Svendsen, and Anja Torsvik, and Ewa Sobala, and Emmet McCormack, and Heike Immervoll, and Josef Mysliwietz, and Joerg-Christian Tonn, and Roland Goldbrunner, and Per Eystein Lønning, and Rolf Bjerkvig, and Christian Schichor
March 2007, Stem cells (Dayton, Ohio),
Gro Vatne Røsland, and Agnete Svendsen, and Anja Torsvik, and Ewa Sobala, and Emmet McCormack, and Heike Immervoll, and Josef Mysliwietz, and Joerg-Christian Tonn, and Roland Goldbrunner, and Per Eystein Lønning, and Rolf Bjerkvig, and Christian Schichor
February 2021, International journal of stem cells,
Copied contents to your clipboard!